Google TrendLAMINE YAMAL (5000+) — "You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "LRRK2-mutant microglia an" (30 stories)

Top Headline Story

The LRRK2 P1446L mutation triggers dopaminergic neurodegeneration via DAPK1-mediated microglial neuroinflammation and neuronal apoptosis
Lead StoryNaturegeneral
Dec 21, 2025

The LRRK2 P1446L mutation triggers dopaminergic neurodegeneration via DAPK1-mediated microglial neuroinflammation and neuronal apoptosis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5WWEUyUlhkMUxhZ18xZC1MN2tKQnNzLWF2azR1MDR6elpvVlpaSFBOalV5RDlud1ZOSlVYTXloREtnbnEtMktudko5SGU2VlNHdmx5VXhYdzZ2c0JGZEhR?oc=5" target="_blank">The LRRK2 P1446L mutation triggers dopaminergic neurodegeneration via DAPK1-mediated microglial neuroinflammation and neuronal apoptosis</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
5000+26m ago

lamine yamal

"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words

500+26m ago

thélyson orélien

Acclaimed Author Denies Using A.I. but Admits Plagiarism

500+36m ago

abdulrahman alfozan

OpenAI engineer arrested in bugging of executive conference room

500+36m ago

pope francis

The Myth of St. Francis

Search Results for "LRRK2-mutant microglia an"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
LRRK2 kinase mediates increased GCase activity in microglia in response to IFNγ-induced proinflammatory stimulation
Naturegeneral

LRRK2 kinase mediates increased GCase activity in microglia in response to IFNγ-induced proinflammatory stimulation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE05ZF82WVR0M2N1MlZJM2RFbzMyeUFpMDNtR2gyY0FPQVVQUElLX0ZhSElVSnhiaHMzWVZZT0ZMNnk4VkhTeDJscnpMSWlkel9KOUNpX3dHVHlyUjVmY3VN?oc=5" target="_blank">LRRK2 kinase mediates increased GCase activity in microglia in response to IFNγ-induced proinflammatory stimulation</a>  <font color="#6f6f6f">Nature</font>

LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF-β1 in Parkinson's Disease
Wiley & Sonsgeneral

LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF-β1 in Parkinson's Disease

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFAzOTlodHRyVG1FT3gyOGNPRFRwNHo2LUFWa3ZQT2tsNTU3ZzNXZWdyNWQ5U0pSYUd5eTlHTV9HQ3l6NDU4cHF5TlVOUGFzMnVNMUlXQTcxN0lOR0pKN2otZ3ZOYTVzMHNxbTctRjVRN2Q4WFFjQlE?oc=5" target="_blank">LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF-β1 in Parkinson's Disease</a>  <font color="#6f6f6f">Wiley & Sons</font>

Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
Frontiersgeneral

Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNNHhEbzNINmJ1UjJFREJWUFVYVFFWZzNIQllVSjVzdFBiWXMwVUN1ZU1pUjBTN2lZX05MRWZuNzkxNDI1T0ZVSGdJOUtmVFpIMDdoWmFyODQtbVBhaGdkZHJsY3BKckNCMVF6Wmw4Uk9YQmdGNU1NSzZaakphU1ZDYl9iR2RjNlIzWU54UGhheHVjdw?oc=5" target="_blank">Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation</a>  <font color="#6f6f6f">Frontiers</font>

LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Journal of Neurosciencegeneral

LRRK2 Inhibition Attenuates Microglial Inflammatory Responses

<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBaU1ZqUEdBQWNVemJqSjlJWjFFVDN4UXdSWnJFNmZtM1dGdDBTMktYaWc5cjBZZDVQY2x4RDBZVU94NFJvRGhqanRCT3BlN1JWMGwyWlhB?oc=5" target="_blank">LRRK2 Inhibition Attenuates Microglial Inflammatory Responses</a>  <font color="#6f6f6f">Journal of Neuroscience</font>

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson’s disease model | Communications Biology
Natureworld

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson’s disease model | Communications Biology

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9hdXY2SU5GOV96Q1ZqVnV5MXQxSjhOR05YZ29XMHFscGJTLW53N2p2d2VfZFpWcWZuM2MtTEc0S1IwTm9OTW9IaFhKcEc2bmRnZmE4b19UalBTSkdmVjVV?oc=5" target="_blank">LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson’s disease model | Communications Biology</a>  <font color="#6f6f6f">Nature</font>

Study reveals insights into link between genetic mutation and Parkinson’s
YaleNewsgeneral

Study reveals insights into link between genetic mutation and Parkinson’s

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPZjJvMmZ6ZW5oaUNDWnlVbjU2U3JYN3JWc3gwUWFUWTBRVmtwTTJNOEgyM1d6NTViY3J5LW9CRHk3eHRZQ0hDWXFKdC1JNDhrM0tUbGM2djA2MGtyRXFCT2JRYTFBaENoVmlEdXR0T3h6MkR5Y215VEtwMEpfdmh0ZTQwM1YtQ0g3LVE5YXlSN29TaVQyWVloUEd3bno4S3JDV0E?oc=5" target="_blank">Study reveals insights into link between genetic mutation and Parkinson’s</a>  <font color="#6f6f6f">YaleNews</font>

Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease
PNASgeneral

Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5WQmNaWU11UjI4SnZkNlEwanN4Tms3Z2dha2NiZ0FrRl9mcUJwOUlaNWlkWG5pcUxQUHktblROekpIRk9NUlFKa0psdFBrR3BNOGJ4aDR1aFNKWG96?oc=5" target="_blank">Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease</a>  <font color="#6f6f6f">PNAS</font>

LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s
Frontiersworld

LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOeWtna00tQWdxLTktWHlQbEhCem9wVWViU2dKWjFfRjdZZ1QzVEVFVE51d3pkVXRsdGxNbGxSOHV4ODdOTzBrdF9ieWNDU1VEOGl5eV8tOGxrZUlCMG1Idng4X1F1enhMY3c2RUhvbmhnMTlENFEwZmVvQVBPNUdQanN4SGlDMU1mNWJNeUI3SF9vZw?oc=5" target="_blank">LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s</a>  <font color="#6f6f6f">Frontiers</font>

Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson’s disease related transcriptional profile and function
Natureworld

Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson’s disease related transcriptional profile and function

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB1X01RWENfUk9reHJEZUNuRGF2SGxFRWRaYjhhdzcwUldJUlZIMHFPc2piTjN5OWZPMkVzb29uNzM4QTRyRm84ZTBxMXMyZGlZWWl4aVJ0R3lQeGY1QzNN?oc=5" target="_blank">Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson’s disease related transcriptional profile and function</a>  <font color="#6f6f6f">Nature</font>

Microglia: roles and genetic risk in Parkinson’s disease
Frontiersgeneral

Microglia: roles and genetic risk in Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPaFBsU3dlWU5TYThuaUZLOFhyUlRGNEFfZkNYRUVxMWRadDVsbFpzZG12UEV4eDR3MkRXYmNsMW43b3pXY3V4LU45ZU9NNGoyNTRVUmZkMzN3NXJBRDVLUVRNWXpRNkVraXM1dGZxa050LVZEX2ItanlVajlHX3pGTzdpYzhQSGNPSk9pT19uUXY5U3B3?oc=5" target="_blank">Microglia: roles and genetic risk in Parkinson’s disease</a>  <font color="#6f6f6f">Frontiers</font>

Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation
Frontiersgeneral

Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQTXVIS0M1YlA1UXR5UHdGZ2JqVDg4MXFDbzVZblhmdW9NZVFRN3J4S3NrSHZUZ0ZBNVF1SFFKeGJyQXlMcXVlR3lCdFY5eEJLck9aWFdMRjFTZm84QzhjM2NKWVBTOEVpYllrWWlSeGQxQzRpeTB0N2FWOVdXUGE3a0oxVXQtMkRLcy0xUXJlU2VhbV9VbHQxMGt3Nk1vZ2xG?oc=5" target="_blank">Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation</a>  <font color="#6f6f6f">Frontiers</font>

LRRK2 deficiency mitigates amyloid β deposition-mediated pathology in a murine Alzheimer’s disease model by reprogramming microglia
Naturegeneral

LRRK2 deficiency mitigates amyloid β deposition-mediated pathology in a murine Alzheimer’s disease model by reprogramming microglia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1USk1yNGREVUVaaXN1SjFwOVBqTFFCak9fckJvVXRvNUpaZGxadHFrN3pyQjRSMEs3YzhiZVpMZ1NGQnZFbTFfdjhwOEc4Zldfb1JWOERRcXFJNVRicFlR?oc=5" target="_blank">LRRK2 deficiency mitigates amyloid β deposition-mediated pathology in a murine Alzheimer’s disease model by reprogramming microglia</a>  <font color="#6f6f6f">Nature</font>

Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson’s disease
Naturegeneral

Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBwdy1aNVFYaTBwRVVadWNIZFhjTHU2ZVVEcTdGZTZieUpTYkxPeE96Wld4TmFXdGt6WmNaNkhHUXlBSXB2dVkzZzFMaFdWbmd4b3dUWGM1QVRhVHhwek40?oc=5" target="_blank">Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson’s disease</a>  <font color="#6f6f6f">Nature</font>

LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
Naturegeneral

LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE85VFJiR2xhakZ6alo4TXA2cW0yZGRBUGlKcnBFU1p0NjhTalVWOVpla2RiR21RYUFMaFJZVXJTMERnV1ZJelZNRnRuZmxscHBSWlFkNg?oc=5" target="_blank">LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase</a>  <font color="#6f6f6f">Nature</font>

Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells
Naturegeneral

Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0wVk1jRXlpVTRBM0w5T2FYS3VxSEREUDJQV3NmcWlENjc3MldLT3pRcWtkNlBEN1Z3M2lUbUZDMGpSdGw3RUUyZXozalNGQjk1MmxLQm9TNy1ZaURjbjZB?oc=5" target="_blank">Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells</a>  <font color="#6f6f6f">Nature</font>

Soluble immune factor profiles in blood and CSF associated with LRRK2 mutations and Parkinson’s disease
Natureworld

Soluble immune factor profiles in blood and CSF associated with LRRK2 mutations and Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1EQzdLa1FoOVM3b2Q3eHQwdHdOS19WYmo1WVJuRjFhc29neHB6bGdZYlM0UEJyZjFVUkdfdFVTT2h4STlYVGFpZTZVTlBra3dHUlFCc2JCRkViRW42cFE0?oc=5" target="_blank">Soluble immune factor profiles in blood and CSF associated with LRRK2 mutations and Parkinson’s disease</a>  <font color="#6f6f6f">Nature</font>

The E193K LRRK2 mutation interferes with the autophagosome processing through the impairment of the LRRK2-Dynein-1 complex
Naturetech

The E193K LRRK2 mutation interferes with the autophagosome processing through the impairment of the LRRK2-Dynein-1 complex

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBLdDVBblBUdEtxLUlrZGFoVUk0QW1YYV9VMWxKdHhVbmExNEljLThKTmZjWlpkbzZpM0JWOWx0X0JtbXNGQklUT2tnaGRGcTljeUpxY20tcHhTZGpwN1pR?oc=5" target="_blank">The E193K LRRK2 mutation interferes with the autophagosome processing through the impairment of the LRRK2-Dynein-1 complex</a>  <font color="#6f6f6f">Nature</font>

Perspective on the current state of the LRRK2 field - npj Parkinson's Disease
Naturegeneral

Perspective on the current state of the LRRK2 field - npj Parkinson's Disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9CZGhuQ1UyUkdzVmVneG1Ualp4MTdKVUlCQV9nOTRINWVZN2o0LUxyUVhic2Q5cHlMWGt4d2RvRXNQM2hXV3daX2JGZGJ2eVdHbjVHNi1zaFpfV1ZVSllF?oc=5" target="_blank">Perspective on the current state of the LRRK2 field - npj Parkinson's Disease</a>  <font color="#6f6f6f">Nature</font>

Interferon gamma stimulates coordinated changes in LRRK2, GCase, and cathepsin activities in idiopathic and genetic Parkinson’s disease monocytes
Naturegeneral

Interferon gamma stimulates coordinated changes in LRRK2, GCase, and cathepsin activities in idiopathic and genetic Parkinson’s disease monocytes

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1yS2hmR2FyWTF2c01WV3JYM29vYl9YeWJGMVdvS3dlcjFnTjhXQ2FFQk15TVVkNzN1UTgySFBaWko1S1FpYUZfMnRSQVBucXZnVUtRZDA3RFZoLVNmN0hR?oc=5" target="_blank">Interferon gamma stimulates coordinated changes in LRRK2, GCase, and cathepsin activities in idiopathic and genetic Parkinson’s disease monocytes</a>  <font color="#6f6f6f">Nature</font>

LRRK2 and Parkinson's disease: from genetics to targeted therapy
Wiley Online Librarygeneral

LRRK2 and Parkinson's disease: from genetics to targeted therapy

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBzMDBWYjlCUm1SdlA5djdRd0l0VXV1cVRMaDl4Nlk5bmQtTXJnazcxWDVWZ2dDWEpvbHdzQVl6UWNDcUtQRFk1WlRQTXE0VkpnX194ck84UGpJdExnQzJtTmwtUTZ4VUh2OUE0?oc=5" target="_blank">LRRK2 and Parkinson's disease: from genetics to targeted therapy</a>  <font color="#6f6f6f">Wiley Online Library</font>

Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
Naturegeneral

Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5PTUstVV9QSWI1Y2dLQzh4SDl3bXAzNVVadVJTLVpkZUZUVVhwSGNiUjl5a2VKN1ZVUjZ1MXk1M29vVlhJVm9EaDgxWEN2ak9wTnB3cUVieVIzcU1hejVr?oc=5" target="_blank">Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages</a>  <font color="#6f6f6f">Nature</font>

LRRK2 mutations may curb certain immune cells’ ability to clear waste
Parkinson's News Todaytech

LRRK2 mutations may curb certain immune cells’ ability to clear waste

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNSVNOZFZ4QWtjV3RwZzEzNVVhYTZ3Q212aTJvQ2t3Zm44eHZ0X3B0UWJyZmJ4ZldISVpGOGxBbVFGWENSbGRnWnN3OGN2cGkzU0JFLU5nN0NQbGE2VFhSYmo0VU5pUXAxTHNHZkVMZzgzLVlBWm44Y2VTem9kYXFNUVd4RkVTZ2phZDhsOEFIR09GdWpzRG1mYkFBWmRZSXlm?oc=5" target="_blank">LRRK2 mutations may curb certain immune cells’ ability to clear waste</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Naturegeneral

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1tTWtqUXhldkFzeXdON01zSWJtQzdCeUtDcFhDZjIwVVB5RTBKVzhFMkRRajRydVV1TVBBRVVOTjVQTnJpQVRrVmh4M2dHZVZndFNvcGxUd2xkRThCRENR?oc=5" target="_blank">Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets</a>  <font color="#6f6f6f">Nature</font>

“LRRK2: Autophagy and Lysosomal Activity”
Frontiersgeneral

“LRRK2: Autophagy and Lysosomal Activity”

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOdTZpN0VGU09Bb0Y2REdiTFZ2MVQ5Ri04THdSSWJpMnJhMkUwT3F2NUVVYUZHaWpqVWtCSFBOYXVpXy1XdDBjTzZYdjlrSlhzZjhtMzdxUHVEbUpLTU41Z2lPRlpDVUJPS3d0RGh1UXZoMTJBY3BaNlFWR0lHbW9Fd2c2VnNGNnNURHFWWkdMcEE2UQ?oc=5" target="_blank">“LRRK2: Autophagy and Lysosomal Activity”</a>  <font color="#6f6f6f">Frontiers</font>

Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons | npj Parkinson's Disease
Naturetech

Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons | npj Parkinson's Disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0tOFZ4bTVNUXg5TFNrMnE5dmJhQXBld2YyMl9zU190OXdyRWIxVVoycXFnRTFMdlBmRlU1d3hBV2hGMF83SFNMS3BvaW15aUY1cW12bkFFc0RDdUFkSzdJ?oc=5" target="_blank">Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons | npj Parkinson's Disease</a>  <font color="#6f6f6f">Nature</font>

Two studies explore LRRK2’s activity in Parkinson’s disease
National Institute on Aging (.gov)general

Two studies explore LRRK2’s activity in Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQWFBsMGQ3TVZON09pZU50T2lzMTJtY2RELUVVclR3b01VbjdhS3g5ZmdkZWdCX1BXWjA4M3JJdGh2bmh0ZkhzMzlLeF82enRJbDVOS1JYei1GS2kwQW1CcV84anR5bUloclZRTmFNNTJma1BaaTlYVm5wQmwxVkZZR3VhU3Y2YkphMHZJ?oc=5" target="_blank">Two studies explore LRRK2’s activity in Parkinson’s disease</a>  <font color="#6f6f6f">National Institute on Aging (.gov)</font>

LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies
Science | AAASgeneral

LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5XLTVzdDUxR0pMNXRzZlZNMXo4N2dZdTFyTEp2aC1jaXRjZFQ1cGUtb2ptckdmRTF3SmRKeWNGbGxWcWpTRzlhOGpjQVMwNXRGcEw1eno1WTBseW5MN3RHOEcwU0hGdjA?oc=5" target="_blank">LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies</a>  <font color="#6f6f6f">Science | AAAS</font>

Leucine Rich Repeat Kinase 2 and Innate Immunity
Frontiersworld

Leucine Rich Repeat Kinase 2 and Innate Immunity

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOTnFKTmE3T2tvTDlpT3V2Si05TWFsQlUxam1sNnVZVzN3WHJOY1QtcWFwLWdNbGZNWnZZdWdSM1NRcWR0cE1TcmY3QUdzMkRUMktDeFU5VER6N1JBeHI1b0FzRGVFZDRCaEl1TVByaGEwckRubks5UEkzZkt5TG40ZlljaFRlSm95dzZrbkZldU9zQQ?oc=5" target="_blank">Leucine Rich Repeat Kinase 2 and Innate Immunity</a>  <font color="#6f6f6f">Frontiers</font>

Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease
Naturegeneral

Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9sQmdqSndhRkF6YnNCNU9EZ0htLTlRMWo1bzJjZnhCc05hd1dmSlhjN19JX2Y2c1Nfc1ZJUGZXWmw5VU1YMHprOTZUc0w5MmZva25kc29aRnRkV1l5dVQ4?oc=5" target="_blank">Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease</a>  <font color="#6f6f6f">Nature</font>

"LRRK2-mutant microglia an" — Live Google News Trends & Headlines